Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy

Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer

(2012) Hyuk-Chan Kwon et al.   BIOMARKERS

Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer

(2011) W Chua et al.   BRITISH JOURNAL OF CANCER

Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer

(2011) Mi Ran Jung et al.   JOURNAL OF SURGICAL ONCOLOGY

Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer

(2011) De-shen Wang et al.   TUMOR BIOLOGY

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008

(2011) Kyu-Won Jung et al.   Cancer Research and Treatment

Oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX-4) Combination Chemotherapy as a Salvage Treatment in Advanced Gastric Cancer

(2010) Young Saing Kim et al.   Cancer Research and Treatment

Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases Treated with Systemic Chemotherapy

(2009) Yoji Kishi et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer

(2009) Do-Kyong Kim et al.   BMC CANCER

Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma

(2008) Richard A. Smith et al.   AMERICAN JOURNAL OF SURGERY